Aptevo Therapeutics APVO
NASDAQ APVO
$1.77 +0.01 (+0.57%)
As of: Oct 2, 2026 · 12:12 PM EDT

Aptevo Therapeutics (APVO) Non-Current Deffered Revenue (2015 - 2017)

Updated

Aptevo Therapeutics (APVO) posted Non-Current Deffered Revenue of $2.8 million for Q2 2017, down 16.3% from $3.34 million a year earlier and down 0.2% from the prior quarter.

Analysis

Aptevo Therapeutics (APVO) Non-Current Deffered Revenue (2015 - 2017) Analysis & Trends

At the end of FY2016, Aptevo Therapeutics' Non-Current Deffered Revenue came in at $2.9 million, down 12.7% from FY2015.

  • In prior years, Aptevo Therapeutics' Non-Current Deffered Revenue was $3.32 million in FY2015.
  • According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $2.8 million (Q1 2017), $2.9 million (Q4 2016) and $3.1 million (Q3 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Aptevo Therapeutics 2.58 Mn -64.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 2.80 Mn
Mar 31, 2017 2.80 Mn
Dec 31, 2016 2.90 Mn
Sep 30, 2016 3.10 Mn
Jun 30, 2016 3.34 Mn
Dec 31, 2015 3.32 Mn
API Access

Aptevo Therapeutics Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=APVO&period=max&api_key=YOUR_API_KEY